Patients demographics for the whole study group
| Variable | n (%) (n=59 patients) |
| Age | |
| ≤16 years | 12 (20.3) |
| >16 years | 47 (79.7) |
| Gender | |
| Male | 44 (74.6) |
| Female | 15 (25.4) |
| Body mass index | Mean 25.4±5.9 (range: 16.33–45.2) |
| Diagnoses | |
| Behçet’s disease | 38 (64.4) |
| Idiopathic panuveitis | 9 (15.3) |
| Chronic recurrent VKH | 4 (6.8) |
| Idiopathic intermediate uveitis | 3 (5.1) |
| Idiopathic anterior uveitis | 3 (5.1) |
| Sarcoidosis | 1 (1.7) |
| Diffuse subretinal fibrosis syndrome | 1 (1.7) |
| Type of biologic therapy | |
| Infliximab | 36 (61) |
| Adalimumab | 14 (23.7) |
| Rituximab | 9 (15.3) |
| COVID-19 test | |
| Positive | 9 (15.3) |
| Negative | 50 (84.7) |
VKH, Vogt-Koyanagi-Harada disease.